Study of Telemonitoring Versus Standard Care in Adults Hospitalized for Heart Failure Evaluating Virtual Ward Follow-Up to Reduce Rehospitalization and Improve Outcomes

What this Trial Is About

Researchers are evaluating whether follow-up care using virtual wards can reduce hospital stays for patients recently hospitalized with heart failure. The study compares virtual ward follow-up with usual care to assess if it decreases heart failure hospitalizations and all-cause mortality at three, six, and twelve months. The research also examines cost-effectiveness, medication use, and quality of life improvements. The study is a randomized, controlled trial conducted at multiple centers in Ireland with patients aged 18 and older. Participants are randomized into two groups standard care and telemonitoring. Both groups have an initial face-to-face appointment within two weeks of hospital discharge. The standard care group receives follow-up with nurse-led face-to-face or phone appointments at weeks 6 and 12. The telemonitoring group receives a tablet, weight scale, and blood pressure monitor if needed and provides daily biometric data and symptom reports. Their follow-up includes scheduled phone or video calls at weeks 4, 6, 8, and 12, with extra visits as required. During the study, participants undergo regular assessments to monitor hospital admissions, mortality, medication use, and quality of life. Clinical events are reviewed by a committee unaware of group assignments. Data collection includes biometric monitoring and symptom tracking for the telemonitoring group. The study duration includes follow-up at three, six, and twelve months, with outcomes evaluated through in-person visits and telephone or virtual appointments. The aim is to understand the impact of virtual ward care on heart failure management over time.

Heart Failure Virtual Ward Research Study